Ozempic Linked to Lower Dementia Risk and Reduced Nicotine Dependence

Oxford study finds significant cognitive and addiction benefits in diabetes patients using semaglutide.

Patients on Ozempic had a 48% lower risk of dementia compared to those on older diabetes drugs.
The study analyzed medical records of over 100,000 US patients, including 20,000 on semaglutide.
Semaglutide users also showed a 28% lower rate of smoking than those on glipizide.
No increased risk of neurological or psychiatric conditions was found in semaglutide users.
Researchers call for randomized controlled trials to confirm these observational findings.